PT HM Sampoerna is investing USD 330 million to establish a state-of-the-art smoke-free tobacco production facility in Indonesia, reinforcing its commitment to innovation in the tobacco industry.
Target Overview
PT HM Sampoerna Tbk. (Sampoerna) is a leading tobacco company in Indonesia, dedicated to transforming the industry through scientific innovation. Recently, during the Technovation event in Jakarta, Sampoerna's CEO, Ivan Cahyadi, emphasized the company's commitment to developing smoke-free products that are rooted in scientific research. This development reflects Sampoerna's goal of providing better choices for adult smokers who prefer to continue using tobacco or nicotine products.
As part of its strategic initiatives, Sampoerna is investing USD 330 million (approximately IDR 5.3 trillion) to launch a state-of-the-art production facility for smoke-free tobacco products in Karawang, West Java. This facility, PMI's first in Southeast Asia and seventh globally, will champion innovative manufacturing practices, combined with a global standard testing laboratory supported by a skilled workforce of 200 local experts.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Indonesia
The tobacco industry in Indonesia is experiencing a significant shift, driven by increased consumer awareness regarding health risks associated with smoking traditional cigarettes. As a result, there has been a growing demand for innovati
Similar Deals
PT Morris Capital Indonesia → PT Multi Makmur Lemindo Tbk
2025
MERIDIANA Capital Markets SE → The New Meat Company AG
2025
Philip Morris International
invested in
PT HM Sampoerna Tbk.
in 2023
in a Other Corporate deal
Disclosed details
Transaction Size: $330M